Last Updated: November 8, 2026

CLINICAL TRIALS PROFILE FOR FINASTERIDE AND TADALAFIL

« Back to Dashboard

All Clinical Trials for FINASTERIDE AND TADALAFIL

Subscribe to access the full database, or Start Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT01139762 ↗	A Study of Tadalafil Use With Finasteride in Men With Enlarged Prostates and Urinary Symptoms	Completed	Eli Lilly and Company	Phase 3	2010-09-01	The purpose of this study is to investigate the efficacy and safety of once daily tadalafil when taken with finasteride as a treatment for men with signs and symptoms of Benign Prostatic Hyperplasia and demonstrable prostate enlargement.
NCT05142254 ↗	A Randomized Controlled Double-Blind Trial for Prevention of Recurrent Ischemic Priapism in Men With Sickle Cell Disease: A Pilot Study	Not yet recruiting	Vanderbilt University Medical Center	Phase 2	2022-03-01	To conduct a randomized controlled internal pilot feasibility trial for the prevention of recurrent ischemic priapism referred to as the Priapism in Nigeria (PIN) trial. The study team will enroll a minimum of 30 participants and a maximum of 200 participants. Study investigators hypothesize that hydroxyurea therapy combined with tadalafil is superior to a combination of hydroxyurea and placebo in the prevention of recurrent ischemic priapism.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for FINASTERIDE AND TADALAFIL

Condition Name

Chart
Table

Condition Name for FINASTERIDE AND TADALAFIL
Intervention	Trials
Benign Prostatic Hyperplasia	1
Enlarged Prostate	1
Priapism Due to Sickle Cell Disease	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for FINASTERIDE AND TADALAFIL
Intervention	Trials
Anemia, Sickle Cell	1
Prostatic Hyperplasia	1
Lower Urinary Tract Symptoms	1
Hyperplasia	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for FINASTERIDE AND TADALAFIL

Trials by Country

Map
Table

Trials by Country for FINASTERIDE AND TADALAFIL
Location	Trials
Canada	4
United States	4
Poland	1
Belgium	1
Germany	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for FINASTERIDE AND TADALAFIL
Location	Trials
Texas	1
Louisiana	1
Florida	1
California	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for FINASTERIDE AND TADALAFIL

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for FINASTERIDE AND TADALAFIL
Clinical Trial Phase	Trials
Phase 3	1
Phase 2	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for FINASTERIDE AND TADALAFIL
Clinical Trial Phase	Trials
Completed	1
Not yet recruiting	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for FINASTERIDE AND TADALAFIL

Sponsor Name

Chart
Table

Sponsor Name for FINASTERIDE AND TADALAFIL
Sponsor	Trials
Eli Lilly and Company	1
Vanderbilt University Medical Center	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for FINASTERIDE AND TADALAFIL
Sponsor	Trials
Industry	1
Other	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.